2026 Private Payer Remote Patient Monitoring Policies

Note: Last updated May 19, 2026. Payer policies, medical necessity guidelines, and reimbursement rates are subject to frequent change without notice. We strongly recommend verifying current coverage and billing requirements directly with the payer prior to claim submission to ensure accuracy and prevent denials. Use of this information does not guarantee payment.

Remote patient monitoring (RPM) has crossed the threshold from a digital health "innovation" to a standard of clinical care. The data in 2026 is undeniable: Consistently monitoring physiologic data between office visits improves patient outcomes and reduces long-term healthcare spending.  

The Centers for Medicare & Medicaid Services (CMS) has continued to embrace RPM, motivated by the proven clinical and financial benefits of the service. In the 2026 Physician Fee Schedule (PFS), CMS finalized two new RPM CPT codes that represent a genuine shift in how remote oversight is valued. CPT 99445 reimburses for 2-15 days of data. CPT 99470 recognizes the first 10-20 minutes of management. The addition of these codes is validation for those who have long believed that every minute of remote care management carries real, measurable worth.

As CMS continues to expand its coverage for RPM, it's worth noting that commercial payer policies can and do differ from traditional Medicare. Understanding and navigating that gap may be what separates thriving RPM programs in 2026 from ones that struggle to maximize the service.

We dive into some of the largest insurers’ commercial and Medicare Advantage (MA) RPM policies below.

What are Anthem’s RPM Policies? 

Anthem remains one of the more flexible payers in 2026, prioritizing the clinician’s judgment over rigid condition lists, provided documentation is robust. 

Anthem’s Medicare Advantage RPM Policy 

Anthem's Medicare Advantage plans continue to mirror Traditional Medicare, covering a broad range of chronic and acute conditions. Anthem MA plans are fully aligned with the 2026 CMS guidelines. This includes the adoption of: 

• CPT 99445: Device supply/transmission for 2–15 days

• CPT 99470: 10-minute management tier designed for acute oversight 

Anthem’s Commercial RPM Policy

Anthem’s commercial policy aligns with Medicare policy, covering RPM across a wide range of chronic and acute conditions with no restrictions, and support for codes 99445 and 99470. 

• Primary Document: Remote Therapeutic and Physiologic Monitoring Services (CG-MED-91) (Updated Dec 2025).

• Policy Detail: Anthem commercial insurance covers RPM for a broad range of chronic and acute conditions. The caveat is the "automatic transmission" rule: data must be uploaded directly from an FDA-cleared device without manual patient intervention to be reimbursable. 

What are Aetna’s RPM Policies?

Aetna has moved toward a high-utilization management model, narrowing the scope of RPM for its commercial population to, in its words, manage rising costs.

Aetna’s Medicare Advantage RPM Policy

Aetna has embraced a condition-specific framework for 2026, creating a narrower path for reimbursement. Under Clinical Policy Bulletin 1093, updated March 1, 2026, Aetna commercial and MA coverage is centered on three core conditions: heart failure, hypertension, and diabetes. While Aetna covers the most common RPM use-cases, Aetna has been slower to adopt the new short-cycle codes.

Aetna’s Commercial RPM Policy

Aetna's commercial RPM policy covers the three most common conditions monitored with RPM and excludes the newer short-cycle codes 99445 and 99470.

• Primary Document: Aetna CPB 1093: Remote Physiologic Monitoring. (Revised April 2026).

• Policy Detail: Highly Restrictive. Effective March 2026, Aetna commercial considers RPM medically necessary only for heart failure, hypertension, and diabetes

• CPT Codes: While Aetna covers the most common RPM use-cases, Aetna has been slower to adopt the new short-cycle codes for its commercial population, largely sticking to the traditional 16-day requirement (CPT 99454) for device supply.

• Strategic Note: Monitoring for conditions like COPD or asthma is now frequently classified as "experimental" under Aetna commercial insurance , requiring secondary appeals or specific clinical exceptions. 

Aetna has provided a transition period. All members monitored prior to the March 1, 2026, update may continue receiving RPM through August 31, 2026, even if they fall outside the new condition list, giving practices time to adjust their programs.

What are UnitedHealthcare’s RPM Coverage Policies?

UnitedHealthcare (UHC) currently presents the highest level of administrative uncertainty due to an announced policy that was retracted and ultimately never implemented.

UHC's attempted restriction of RPM policy represented a jarring departure from industry norms, labeling RPM as 'proven' only for chronic heart failure (HF) and hypertensive disorders of pregnancy (HDP), and categorizing monitoring for primary hypertension and Type 2 diabetes as “unproven”  — a claim that ignores years of clinical data and CMS policy. The policy faced significant pushback from providers and industry stakeholders, ultimately forcing UHC to delay its implementation and go back to the drawing board. The coverage criteria that ultimately emerges will likely look different from what was originally announced.

UHC’s Medicare Advantage RPM Policy

Unlike many other insurers that defer strictly to CMS on Medicare Advantage guidelines, UHC originally published a restrictive medical policy intended to apply to its MA plans as well. Following fierce backlash from medical societies, advocacy groups, and other affected parties, UHC indefinitely delayed the implementation of these restrictions for MA. For now, MA coverage remains aligned with standard CMS definitions, but the initial attempt to restrict these plans suggests a high degree of regulatory volatility. 

UHC’s Commercial RPM Policy

UHC's commercial policy mirrored its Medicare Advantage counterpart in signaling a sharp restriction to just two conditions, but like its MA policy, the scale-back was indefinitely delayed following industry pushback.

• Primary Document: UnitedHealthcare Medical Policy Update Bulletin (2026)

• Policy Detail: In late 2025, UHC signaled a shift to limit RPM strictly to heart failure and pregnancy-related hypertension. However, this policy was indefinitely delayed as of May 2026 following industry-wide pushback.

• Current Status: Coverage remains broad for most standard chronic conditions, but providers should keep an eye on UHC’s policy bulletin for the latest updates. Follow us on LinkedIn for the latest updates in remote care.  

What are Cigna’s RPM Policies?

Cigna balances flexibility with a defined list of evidence-based applications, focusing on high-risk conditions.

Cigna’s Medicare Advantage RPM Policy

Cigna MA plans utilize the full 2026 CPT code set, including the "short-cycle" logic for post-acute monitoring where 16 days of data may not be feasible.

Cigna’s Commercial RPM Policy

Cigna's commercial policy takes a condition-specific approach, covering a defined list that includes COPD, diabetes, heart failure, and hypertensive disorders of pregnancy, and extends coverage to codes 99445 and 99470. The policy notably does not cover RPM for primary hypertension. Instead, Cigna only covers self-measured blood pressure (SMBP).

• Primary Document: Cigna Medical Coverage Policy 0563: Remote Physiologic Monitoring and Remote Therapeutic Monitoring. (Updated May 2026).

• Policy Detail: Cigna covers RPM for a specific list of conditions, including hypertensive disorders of pregnancy (HDP) and COPD, alongside diabetes and heart failure. Notably, Cigna excludes hypertension from its commercial policy, only reimbursing for SMBP monitoring (CPT codes 99473, 99474).

• Requirement: Cigna emphasizes that RPM must be "integrated" into a 30-day treatment plan; standalone monitoring without a documented clinical response is frequently denied. 

What are Humana’s RPM Policies?

Humana is a Medicare Advantage powerhouse but maintains a "transparency gap" in its commercial guidelines.

Humana’s Medicare Advantage RPM Policy

 Humana’s reference to the Medicare Learning Network (MLN) Booklet MLN901705 indicates an alignment with CMS policy, signifying that their Medicare Advantage plans do not limit RPM to a narrow list of chronic conditions and recognize the 2026 reimbursement updates for 99445 and 99470. 

Humana’s Commercial RPM Policy

Despite extensive research, specific publicly available documentation for Humana's 2026 commercial RPM policy was not found. As with all payers, we recommend confirming current coverage and requirements directly with Humana before billing.

The Government Push and New Care Models

The federal trajectory for RPM is one of aggressive expansion. CMS is no longer just "testing" RPM. The agency is architecting care models around the primary principles of RPM.

The reasoning is simple: preventive care in the form of remote patient monitoring is longitudinally cheaper than emergency care. The growing body of clinical evidence supports RPM as an extremely effective approach for managing chronic diseases. As federal and commercial models generate more success data, the pressure on private "outliers" to align will likely become insurmountable. 

Prevounce is here to help you navigate shifts in RPM policy, ensuring your RPM program remains compliant. Follow us on LinkedIn or subscribe to our blog to stay up to date with the latest industry updates.

Disclaimer

Health economic and reimbursement information provided by Prevounce is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules, and policies. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.

Prevounce encourages providers to submit accurate and appropriate claims for services. It is always the provider’s responsibility to determine medical necessity, the proper site for delivery of any services, and to submit appropriate codes, charges, and modifiers for services rendered. It is also always the provider’s responsibility to understand and comply with Medicare national coverage determinations (NCD), Medicare local coverage determinations (LCD), and any other coverage requirements established by relevant payers which can be updated frequently.

Prevounce recommends that you consult with your payers, reimbursement specialists, and/or legal counsel regarding coding, coverage, and reimbursement matters.

Payer policies will vary and should be verified prior to treatment for limitations on diagnosis, coding, or site of service requirements.